Media Releases | InSphero
Oct 26, 2017

October 26, 2017 – InSphero and Charles River Announce PDX Partnership

October 26, 2017 – InSphero and Charles River Announce PDX Partnership Charles River to license PDX lines to InSphero for development of 3D InSight™ PDX Microtissues, expansion of in vitro […]

Read More
 
 
Oct 18, 2017

October 18, 2017 – InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC

InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC New 3D InSight™ Human Liver Fibrosis Model represents a powerful tool for screening efficacy […]

Read More
 
 
Jun 29, 2017

June 29, 2017 – Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury

Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury Archives of Toxicology publication reveals microtissues are twice as sensitive as […]

Read More
 
 
Jun 19, 2017

June 19, 2017 – ADA Presentations Highlight Superior Functionality of InSphero Standardized Islet Microtissues for Diabetes Drug Screening

ADA Presentations Highlight Superior Functionality of InSphero Standardized Islet Microtissues for Diabetes Drug Screening ETH Zurich researchers present single-islet study using novel microfluidic setup to display in vivo-like temporal insulin […]

Read More
 
 
May 03, 2017

May 03, 2017 – InSphero Announces Collaboration with NIH National Center for Advancing Translational Sciences (NCATS)

InSphero Announces Collaboration with NIH National Center for Advancing Translational Sciences (NCATS) Joint study will accelerate development of physiologically relevant 3D models for anti-cancer drug screening. PDF Version Schlieren, Switzerland […]

Read More
 
 
Apr 27, 2017

April 27, 2017 – InSphero Announces Agreement with Pfizer to Develop Novel Assays for Predicting Drug-induced Liver Injury

InSphero Announces Agreement with Pfizer to Develop Novel Assays for Predicting Drug-induced Liver Injury Research effort will use InSphero 3D InSight™ Human Liver Microtissues to develop novel assays to predict […]

Read More
 
 
Apr 18, 2017

April 18, 2017 – NIH/NCATS and InSphero Host Inaugural 3D Tumor Model Standards Working Group at AACR 2017

NIH/NCATS and InSphero Host Inaugural 3D Tumor Model Standards Working Group at AACR 2017 Establishing standards for next-generation tumor models to benefit drug discovery and broader research community primary objective […]

Read More
 
 
Apr 03, 2017

April 03, 2017 – Novel 3D Cell-based Assays Accelerate Discovery for Immuno-oncology/CAR-T Therapies

Novel 3D Cell-based Assays Accelerate Discovery for Immuno-oncology/CAR-T Therapies InSphero presents latest data demonstrating immune cell interaction with 3D tumor models for in vitro efficacy testing of oncology drugs and […]

Read More
 
 
Mar 27, 2017

March 27, 2017 – InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing

InSphero 3D Liver Microtissues Featured at Annual SOT Meeting as More Sensitive Model for DILI and Mechanistic Toxicity Testing Customer and company presentations highlight InSphero 3D InSight™ Liver Microtissues as [...]

Read More
 
 
Mar 16, 2017

March 16, 2017 – InSphero Launches 3D InSight™ Monkey Liver Microtissues at Annual Society of Toxicology Meeting

InSphero Launches 3D InSight™ Monkey Liver Microtissues at Annual Society of Toxicology Meeting 3D liver microtissues comprised of cynomolgus hepatocytes provide physiologically relevant in vitro model for investigating species-specific liver […]

Read More
 
 
Feb 02, 2017

February 02, 2017 – InSphero to Introduce GravityTRAP™ 384 Microtissue Platform at SLAS2017

InSphero to Introduce GravityTRAP™ 384 Microtissue Platform at SLAS2017 Global leader in 3D cell culture technology to deliver standardized 3D models in new high-throughput, high-content-imaging-optimized format. PDF Version Schlieren, Switzerland […]

Read More